Mutant SOD1 protein aggregation has been suggested as responsible for amyotrophic lateral sclerosis (ALS), although the operative mediating factors are as yet unestablished.
Introduction
Amyotrophic lateral sclerosis (ALS) is a fatal, adult-onset neurodegenerative disease characterized by a selective loss of motoneurons in the spinal cord and brainstem (1) .
Mutation of Cu/Zn-superoxide dismutase (SOD1) is the most frequent cause of familial ALS (2) . Introduction of such mutated SOD1 genes into mice causes ALS-like symptoms characterized by the selective death of spinal motoneurons, despite a ubiquitous mammalian central nervous system, are composed of a heteromeric complex of four subunits GluR1 to GluR4, and the absence of GluR2 renders the receptor Ca 2+ -permeable (20) . Since this unique property of GluR2 is generated posttranscriptionally by RNA editing, an editing failure can also produce Ca 2+ -permeable AMPA receptors (21) .
Reduced editing efficiency of GluR2 mRNA has been specifically reported in spinal motoneurons from human sporadic ALS patients (22) , further suggesting that Ca 2+permeable AMPA receptor-mediated excitotoxicity is closely linked to the vulnerability of spinal motoneurons in ALS. However, whether and in what manner this atypical type of AMPA receptor affects mutant SOD1-induced motoneuronal degeneration remains to be elucidated.
The purpose of the present study was to explore a mechanistic link between glutamate toxicity and the conversion of mutant SOD1 into aberrant forms by modification of the electrophysiological properties of motoneuronal AMPA receptors in an ALS mouse model. The chat-GluR2 transgenic mouse line was generated to overexpress GluR2 in a cholinergic neuron-specific manner, resulting in a large reduction in Ca 2+ -permeability of motoneuronal AMPA receptors. We detected various types of abnormally folded SOD1 proteins in fractions derived from different cellular compartments from hSOD1 G93A mice spinal cords. Double transgenic mice carrying both chat-GluR2 and hSOD1 G93A displayed a marked delay of disease onset, followed by delayed formation of all the abnormal SOD1 species. These results indicate that Ca 2+permeable AMPA receptors in motoneurons contribute to the conformational changes of mutant SOD1 and the subsequent neurodegeneration associated with these changes. was used to preferentially increase GluR2 expression in spinal motoneurons. Three independent chat-GluR2 transgenic lines, Tg3, Tg7, and Tg10 were established. To examine the copy number of the chat-GluR2 transgene, Taqman quantitative DNA PCR and genomic southern blotting were performed. Results from Taqman PCR indicated that the Tg3, Tg7, and Tg10 lines contained approximately 2, 10, and 16 copies of the chat-GluR2 transgene, respectively, a finding which was also supported by genomic southern blotting ( Fig. 1B) . Expression patterns of the transgenes in the spinal cord were examined using in situ hybridization (Fig. 1C) , revealing a preferential transcription of transgenes in cholinergic neurons in chat-GluR2 mice. To quantify the GluR2 mRNA level in spinal motoneurons, motoneurons were carefully purified from frozen slices of spinal cord using laser microdissection, because other neuronal populations such as dorsal horn neurons express high level of GluR2. Quantitative PCR analysis revealed that spinal motoneurons in Tg7 expressed levels of GluR2 mRNA nearly five-fold higher than those of nontransgenic control mice (Table 1) . Tg10 included numerous copies of the transgene, but displayed lower levels of GluR2 expression than Tg7, probably due to DNA methylation between wt and Tg7 (p < 0.001). The rectification index, an index of Ca 2+ -permeability calculated as the ratio of chord conductance at +40 mV and -70 mV, was estimated as 0.262 ± 0.024 for wt and 0.436 ± 0.038 for Tg7 (mean ± s.e.m., p < 0.001). Thus, the majority of AMPA receptors in spinal motoneurons were Ca 2+ -impermeable in Tg7 mice, but were Ca 2+ -permeable in non-transgenic controls.
Crossbreeding hSOD1 G93A transgenic mice with chat-GluR2 transgenic mice markedly delays disease onset and mortality
The chat-GluR2 transgenic mouse was mated with a hSOD1 G93A transgenic ALS mouse to generate double transgenic (GS) mice. Most of the spinal motoneuronal AMPA receptors were actually Ca 2+ -impermeable in GS mice, but Ca 2+ -permeable in littermates carrying only the hSOD1 G93A transgene (S mice, Fig. 2A ). The G1L line of hSOD1 G93A 7 mice develops overt symptoms defined as disease onset at around 7-months, a classification based on a sudden decrease in motor performance in behavioral tests such as the rotarod test (24, 25) . Death occurs at around 8.5 to 9-months-old. To evaluate the effects of reduced Ca 2+ -permeability in AMPA receptors on the clinical course of ALS, motor performance was assessed by the rotarod test. Fig. 2B depicts the rotarod score of each mouse measured every week, clearly showing that mice carrying the SOD1 G93A gene are rapidly declining in performance score after a certain period. The day just before the decline in score was defined as the day of disease onset, and the mean time of disease onset was compared between S and GS littermates. Disease onset in GS mice was delayed, by 42.9 days (19.5%) in Tg7 and 18.7 days (8.5%) in Tg10, as compared with S mice.
Lifespan was also prolonged in GS mice, by 37.5 days (14.3%) in Tg7 and 15.2 days (5.7%) in Tg10 (Fig. 2C , Table 2 ). No significant difference in rotarod score or lifespan was observed between the chat-GluR2 and wt mice (data not shown). Furthermore, no prolongation of lifespan was observed in GS mice generated from Tg3 (data not shown), which animals displayed no additional GluR2 expression in spinal motoneurons ( Table 1 ).
The number of motoneurons in the spinal cord was counted, revealing that degeneration of motoneurons was also delayed in GS mice from the Tg7 line ( Fig. 2D ). All these results indicate that reducing Ca 2+ -permeability in AMPA receptors delays disease onset and motoneuron death caused by mutant SOD1, presumably in a dose-dependent manner.
affected by overexpression of GluR2. Of the numerous events accompanying disease onset in hSOD1 G93A mice, we focused on cytochrome c-release from mitochondria and induction of cyclooxygenase-2 (cox-2), as a treatment of hSOD1 G93A mice with agents inhibiting these events delays disease onset (25, 26) . Cytochrome c, which is normally localized to the intermembrane space of mitochondria, activates caspases and subsequent apoptosis after release into the cytosol (27) . Cox-2 catalyzes the synthesis of prostaglandin E2, which stimulates glutamate release from astrocytes and plays a key role in the inflammatory process (28) . Cytosolic extracts (25) and RNA were prepared from the spinal cord lumbar region, as this is the most severely affected region in ALS.
Cytochrome c became clearly detectable in the cytosolic fraction around 7-months in S, but was only faintly detectable even at 8-months-old in GS littermates, indicating that the release of cytochrome c is considerably delayed in GS mice (Fig. 3A ). Induction of cox-2 transcription was also significantly delayed in GS in comparison to S littermates ( Fig. 3B ).
After disease onset, hSOD1 G93A mice exhibit severe gliosis in the spinal cord due to exacerbated inflammation (29) . We also found that astrogliosis was remarkably delayed in GS mice ( Fig. 3C ). Reducing Ca 2+ -permeability of AMPA receptors is thus likely to affect the upstream events of cytochrome c-release and cox-2 induction among the processes triggered by mutant SOD1 proteins.
Mutant SOD1 protein is converted into various unusual forms in different cellular compartments, but the conversion is markedly delayed by GluR2 overexpression
The misfolding and subsequent conformational changes in mutant SOD1 proteins are hypothesized to be responsible for the death of motoneurons in SOD1-related ALS (5, 9, 10) . Most SOD1 proteins are located in the cytosol, but very small populations are found in organelles such as mitochondria (30) and nuclei (31) . Therefore, we roughly divided a homogenate from the lumbar spinal cord into a crude mitochondrial fraction and a post-mitochondrial fraction by simple centrifugation (30) , and analyzed in which fraction the misfolded and hence high-molecular-weight-shifted SOD1 proteins were detectable. Most organelles and cytoskeletons were found to be contained in the crude mitochondrial fraction, while cytosolic proteins were in the post mitochondrial fraction (data not shown).
Since the post-mitochondrial fraction contained an extremely large amount of SOD1 proteins, it was a formidable task to detect high-molecular-weight-shifted SOD1 species in this fraction by conventional western blotting (data not shown). To enhance the sensitivity of detection, the post-mitochondrial fraction was size-fractionated using sizeexclusive chromatography with high-performance liquid chromatography (HPLC), and the HPLC fractions were immunoblotted. The results as shown in Fig. 4A indicated that, in addition to the very large amount of SOD1 monomers, high molecular-weight-shifted SOD1-immunopositive species corresponding to dimer (*2), trimer (*3), and tetramer (*4) sizes of mutant SOD1 were detectable in 2-, 6-, and 8-month-old S mice, respectively ( Fig. 4A) . These oligomer-sized species were not observably detected in the lumbar spinal cord from wt or the cerebrum from S littermates even at 8-months-old, suggesting that conversion of the SOD1 protein into oligomer-sized forms preferentially occurs in the spinal cord. The molecular shifts of those species were not due to ubiquitination since they were not detected by anti-ubiquitin antibody ( Supplementary   Fig. 1 ). Formation of oligomer-sized SOD1 aberrant forms was significantly delayed in by guest on November 4, 2016 http://hmg.oxfordjournals.org/ Downloaded from GS compared with S littermates. On the other hand, western blotting of the crude mitochondrial fractions revealed that a significant population of SOD1 proteins in this fraction was converted into species distinct from those found in the post mitochondrial fractions (Fig. 4B ). In addition to dimer-sized SOD1, two major species between the monomer and dimer sizes (approximately 25 kDa and 35 kDa) were detected in symptomatic mice. Formation of all the unusual species in crude mitochondrial fractions was also delayed by more than 1 month in GS compared to S littermates.
Certain populations of SOD1 proteins, probably growing aggregates, can be efficiently trapped onto membranes composed of cellulose acetate, and these filtertrapped SOD1 species extensively increased in tandem with disease progression in mutant SOD1 transgenic mice (10) . Fig. 4C indicates the filter-trapped SOD1 aggregates were considerably increased during disease onset in S mice, but increased more slowly in GS compared with S littermates.
Unusual SOD1 species first accumulate in the fractions dense with neurofilaments,
GFAP, nuclei, and mitochondria, which accumulation is markedly delayed by

GluR2 overxpression
The finding of unusual SOD1 species depicted in Figure 4 led us to do further subcellular fractionation analysis in order to define in which cellular component such unusual species are localized. We thus divided the lumbar spinal cord into four different organelleenriched fractions (P1-P4) and a supernatant fraction (S) consisting of cytosolic proteins ( Fig. 5A ). Immunoblots of these fractions revealed unusual SOD1 species (*) first appeared in the P1 and P2 fractions long time before disease onset, and then, intensively accumulated into the P1 fraction by the disease onset ( Fig. 5B ). Nuclei and certain kinds of cytoskeletons such as neurofilamants and GFAP were effectively concentrated into the P1 fraction, whereas mitochondria are concentrated into the P2 fraction. In S mice, the dimer-sized species were first detected in the P1 and P2 fractions at 4-months. At 7months, the stage of disease onset, the P1 fraction contained a considerable amount of unusual SOD1 species of approximately the size of a dimer, 25 kDa, and 35 kDa, which were very similar to those detected in the crude mitochondrial fractions as depicted in Fig.   4B . These species were only weakly detected in P2, P3, and P4 fractions at the stage of disease onset but then accumulated with disease progression. All these unusual SOD1 species were hardly detectable in the cerebrum, cerebellum, testis, and muscle from S mice even at end stage (data not shown for cerebellum and muscle), and were hardly detectable in the spinal cord from 9-month-old wt littermates. In GS littermates, dimersized species were faintly detected in the P1 and P2 fractions at 6-months of age. Other species accumulated to an enormous extent in the P1 fraction at 8-months of age, the stage of disease onset in GS mice, indicating that the formation of these unusual SOD1 species was delayed concomitantly with the delay of disease onset in GS compared with S littermates. These observations strongly suggest that the misfolding and subsequent conformational changes of mutant SOD1 proteins are delayed when the Ca 2+permeability of AMPA receptors is significantly reduced.
The increase of oxidatively modified proteins is attenuated by GluR2 overexpression
Although the mechanism underlying the marked effects of reduced AMPA receptor Ca 2+permeability on the conformational changes of mutant SOD1 is currently unclear, the attenuation of cellular oxidative stress may be involved. Oxidation of human SOD1 proteins in vitro causes cleavage and/or conjugation (32) , resulting in formation of various types of unusual SOD1 species (33, 34) . Moreover, elevated cellular oxidative stress and resulting oxidative modification of proteins and lipids such as carbonylation are reported in spinal cords from hSOD1 G93A mice (35) (36) (37) . Thus, we compared the level of carbonylated proteins in spinal cord extracts between S and GS littermates, taking it as a marker of cellular oxidative stress. The results in Fig. 6 reveal that carbonylated proteins in spinal cords increased only gradually before disease onset, then, increased substantially at disease onset in both S and GS mice. Such drastic increase was not observed in the extracts from cerebrum even in 9-month S mice. Statistical analysis revealed that the increase of carbonylation was significantly delayed, by at least 2 months, in GS compared with S littermates. This delay of protein oxidative modification might help explain why conformational changes of SOD1 proteins are delayed in GS mice.
Discussion
Motoneuronal Ca 2+ -permeable AMPA receptors contribute to selective cell death in
SOD1-related ALS
The present study demonstrates that motoneuronal Ca 2+ -permeable AMPA receptors contribute to the development of SOD1-related ALS. Reducing permeability by motoneuron-preferential GluR2 overexpression significantly prolongs the lifespan of ALS mice by delaying disease onset (Figs 2B and C). The mutant SOD1 protein level in the ventral spinal cord was not significantly different between S and GS littermates ( Supplementary Fig. 2) , and GluR2 mRNA level in spinal motoneurons did not significantly change during the course of disease in hSOD1 G93A mice (data not shown).
Thus, the beneficial effects of GluR2 overexpression do not result from either a reduction of mutant SOD1 expression or a simple compensation of decreased GluR2 expression, but from reduced Ca 2+ -influx through motoneuronal AMPA receptors.
A recent study on chimeric mice between wild type and mutant SOD1 transgenic mice revealed that the death of motoneurons expressing mutant SOD1 can be delayed when the surrounding non-neuronal cells do not express mutant SOD1 (38) . This finding indicates that motoneuronal death triggered by mutant SOD1 is not cell-autonomous, but also depends on the interactions with surrounding glial cells expressing mutant SOD1.
However, there must be a reason why only motoneurons die among the neurons surrounded by non-neuronal cells expressing mutant SOD1. The present study provides evidence that the expression of Ca 2+ -permeable AMPA receptors confers a critical feature on motoneurons such that they undergo death in response to mutant SOD1 effects within themselves and surrounding cells.
Ca 2+ -influx though motoneuronal AMPA receptors promotes conversion of SOD1 protein into aberrant forms
In addition to delaying the disease onset, GluR2 overexpression succeeded in delaying the conversion of SOD1 protein into unusual forms (Figs 4 and 5B) . To date, more than twenty papers have reported the delay of disease onset in mutant SOD1 transgenic mice by various pharmacological or transgenic techniques (1) . However, the effects of such trials on SOD1 conformational changes have yet to be shown. We here provide the first evidence that disease onset is delayed when conversion of SOD1 into unusual forms is delayed, consistent with the hypothesis that SOD1 aggregation participates in ALS pathogenesis.
This study also provides an outline of the temporal profile for the formation of unusual SOD1 species during the clinical course of mouse ALS. Previous studies with western blots detected two distinct patterns of unusual SOD1 species in spinal cord extracts from mutant SOD1 transgenic mice. One is a set of oligomer-sized species (9), and another contains species between a monomer and dimer in size (10) (11) (12) . We here show that trimer and tetramer-sized species are detectable in the post-mitochondrial fractions containing cytosolic proteins (Fig. 4A) , whereas species between a monomer and dimer in size are detected in the crude mitochondrial fractions containing major cellular components such as organelles and cytoskeleton. On the other hand, dimer-sized species were detectable in both fractions ( Fig. 4B and Fig. 5B ). The amount of trimer and tetramer-sized species in the cytosol seemed comparatively very small to the unusual species in the organelle/cytoskeleton fractions, since these species are no longer detectable in Fig. 5B , an experiment in which the same subcellular fraction amounts were loaded to the respective lanes. The first detectable unusual SOD1 species are dimer-sized species that appear several months before disease onset. Subsequently, a very small population of SOD1 proteins grows into trimer-and tetramer-sized species in the cytosol.
On the other hand, a large amount of SOD1 protein is converted into approximately 25 kDa and 35 kDa-sized species. These unusual species first appear in the P1 and P2 fractions and then extensively accumulate into the P1 fraction by disease onset. The presence in the P2 mitochondrial fraction might be related to the dysfunction of mitochondria that has been reported in hSOD1 G93A mice around disease onset (1, 30) In the P1 fraction, nuclei and certain kind of filamentous cytoskeletons such as neurofilaments and GFAP, but not actin filaments or microtubles, are effectively concentrated. The extensive accumulation of unusual SOD1 species in the P1 fraction implies these species are fundamentally associated with neurofilaments or GFAP, since a further fractionation study revealed these species do not independently accumulate in the nuclei (data not shown). Abnormalities in the neurofilaments observed in ALS patients and mutant SOD1 mice, such as an accumulation of neurofilament inclusions (1) and a defect in axonal transport (4), might be closely related to this phenomenon. Alternatively, those SOD1 species might be involved in aggresome-like structures, as observed in HEK293 cells transfected with G85R and G93A SOD1 mutants (9) . After disease onset, unusual species spread to other organelle fractions enriched in mitochondria, lysosomes, peroxysomes, and microsomes derived from the endoplasmic reticulum (ER), Golgi apparatus, and plasma membrane. These alterations in SOD1 proteins are thought to predominantly occur in motoneurons and surrounding astrocytes, since SOD1-containing by guest on November 4, 2016 http://hmg.oxfordjournals.org/ Downloaded from proteinacious inclusions, which are likely to have developed from high-molecularweight-shifted SOD1 species, are specifically detected in motoneurons and neighboring astrocytes in end-stage hSOD1 G93A mice (6) (7) (8) . The reduction of Ca 2+ -influx through motoneuronal AMPA receptors successfully delayed the formation of the entire range of unusual SOD1 species in spinal cord extracts (Figs 4 and 5A) as well as the development of astrogliosis (Fig. 3C) . These results suggest that Ca 2+ -influx through motoneuronal AMPA receptors can affect the physiology of neighboring astrocytes as well as their own, and contributes to the misfolding and subsequent conversion of SOD1 protein.
Ca 2+ -influx through AMPA receptors enhances ROS production, which may induce the misfolding of SOD1 proteins
Ca 2+ -influx through motoneuronal AMPA receptors seems to enhance oxidative stress primarily in motoneurons and secondarily in neighboring astrocytes. Activation of Ca 2+permeable AMPA receptors causes rapid increases in the level of cytosolic calcium, which are rapidly attenuated by a trapping with Ca 2+ -chelating proteins and by incorporation of calcium into mitochondria and the endoplasmic reticulum (39) . Since spinal motoneurons are less capable of buffering increased calcium levels, probably due to a lack of major Ca 2+ -chelating proteins such as parvalbumin and calbindin D28K (40), a large proportion of free calcium is reported to be incorporated into mitochondria, resulting in enhanced ROS production (41) . Evidence suggests that ROS generated in motoneurons can exit from the motoneurons and cause oxidative disruption of glutamate transporters and increased ROS level in neighboring astrocytes (42) . The loss of astrocytic glutamate transporters, which has been preferentially observed in the affected area in ALS patients and mouse models (15, 42, 43) , accelerates AMPA receptormediated Ca 2+ -influx and ROS generation within motoneurons, resulting in a vicious cycle to enhance the oxidative stress in motoneurons and neighboring astrocytes (44) .
Enhanced ROS levels might, in part, account for the formation of unusual SOD1 species, since oxidative modification by ROS has been shown to convert SOD1 proteins into a variety of unusual forms, at least in vitro (33, 34) . We found a good correlation between the levels of carbonylated proteins and unusual SOD1 species in the spinal cord extracts from S and GS mice. Both levels were rapidly increased at disease onset, but these increases were similarly attenuated when the Ca 2+ -permeability of AMPA receptors was reduced (Figs 4, 5B, and 6 ). This correlation may imply that the increased cellular oxidative stress resulting from activation of motoneuronal Ca 2+ -permeable AMPA receptors induces the misfolding and subsequent conversion of SOD1 protein within motoneurons and adjacent glial cells. 
Materials and Methods
The sequence information for the primers and probes is described in Supplementary   Table 1 
Generation of GluR2 transgenic mice
The transgene construct contained the 6.4-kb promoter region of the mouse ChAT gene 
Electrophysiological recordings
Electrophysiological experiments were performed as previously described (45) 
Quantitative analysis of gene expression levels in motoneurons
Spinal cords from mice at 6-to 8-months-old were dissected without fixation, immediately embedded in OCT compound (Tissue-Tek), and frozen in liquid nitrogen.
Frozen sections 30-µm thick were processed and stained using 0.01% toluidine blue, and motoneurons in spinal cords were clipped out of sections using laser microdissection (AS LMD, Leica) according to the manufacturer's protocol. About 1000 clipped slices of motoneurons were collected per mouse and subjected to RNA purification using an RNeasy kit (QIAGEN), followed by cDNA synthesis primed with oligo dT using Superscript II (GIBCO-BRL). The gene expression level was examined by Taqman realtime quantitative PCR using probe/primer sets specific to target genes. PCR was performed on an ABI7700 thermalcycler (PE Biosystems) under the manufacturer's recommended conditions, using cDNA derived from 60 (for GluR2-4 and ChAT) or 10 (for SOD1 and GAPDH) clipped slices of motoneurons as templates. Data was normalized with the expression level of GAPDH, and presented as a relative expression level compared with the level in the C57BL/6J non-transgenic control mouse.
Animals
Non-transgenic littermates without any transgene are indicated as wt to distinguish them from non-transgenic control mice, C57BL/6J mice. All data except for Table 1 and Fig.  1E are comparisons among littermates. The G1L line of transgenic mice harboring the G93A-mutated human SOD1 gene (B6SJL-TgN(SOD1-G93A)1Gur dl ) was purchased from Jackson Laboratories and backcrossed with C57BL/6J mice. We used the littermates generated by crossing male hSOD1 G93A mice (fourth backcross-generation) with female chat-GluR2 transgenic mice for all analyses except for a study of disease onset and mortality in Tg10 line ( Table 2 and Fig. 2B and C) , that involved three S and three GS littermates generated from the third backcrossed hSOD1 G93A mouse. To determine the day of disease onset, mice were subjected to the rotarod test (46) . The retention time on a rotating wheel, the rotarod score, was measured 4 times per day with a 1-week interval in a blind fashion. Each trial lasted a maximum of 5 min, during which time the wheel rotates with a linear acceleration from 16 to 32 r.p.m. The day of disease onset was defined as the day just before the mean retention time of 4 trials was sequentially shortened to <80% of the previous time. The end time was defined as the day of death or the day when the mouse was unable to right itself within 30 s (24).
Preparation of crude mitochondrial and post mitochondrial fractions
Crude mitochondrial and post mitochondrial fractions were prepared according to an established method (30) with certain modifications. The BSA concentration in buffer H was reduced to 0.1%. The spinal cord L1-L5 segments were homogenized in buffer H (1 mg tissue/10 µl buffer H) on ice and centrifuged at 600 x g for 5 min at 4 °C to remove unbroken cells. The supernatant was centrifuged at 13,500 x g for 10 min at 4 °C, dividing into pellet (crude mitochondrial fraction) and supernatant (post mitochondrial fraction).
Size-exclusive chromatography
Approximately 200 µg of cytosolic extracts were filtered through Millex-HV PVDF filters (Millipore, 0.45-µm diameter), concentrated with a Vivaspin column (Vivascience, cut-off size, MW 10,000), then resolved on a Superdex200 PC3.2/30 column (linear fractionation range, MW 10,000 -600,000; bed volume, 2.4 ml; Pharmacia Biotech) at a flow rate of 40 µl/min in 50 mM sodium phosphate with 150 mM NaCl, pH 7.0.
Fractionation started when 800 µl was eluted, and a 30 µl/tube of elutant was collected for a total of 48 tubes. Void volume was determined by the elution profile of dextran blue (2000 kDa). The column was calibrated using gel filtration calibration kits for high and low molecular weights (Amersham Bioscience). µl buffer) with a glass-Teflon homogenizer (10 up-and-down strokes) on ice, and centrifuged at 600 x g for 10 min. The supernatants were sequentially centrifuged at 5,000 x g for 15 min, 8,000 x g for 15 min, and 100,000 x g for 1 h, to obtain three pellets (P2, P3, and P4) and the resulting supernatant (S). The pellets generated by the first brief centrifugation were very gently suspended with 2.2 M sucrose containing complete protease inhibitor cocktail (1mg starting tissue/15 µl), and centrifuged at 40,000 x g for 1 hr. The resulting pellets (P1) were rinsed with modified Buffer H followed by a centrifuge at 12,000 x g for 10 min. The pellets of P1, P2, P3, and P4 were finally resuspended with 1/4, 2, 1/2, and 1/2 volume (µl) of modified Buffer H per starting tissue weight (mg), respectively. All centrifugations were performed at 4 °C.
Subcellular fractionation
Measurement of protein carbonylation
Freshly dissected tissues were sonicated in buffer (50 mM Tris-HCl, pH 7.6, 20 mM Na 4 P 2 O 7 , 20 mM sodium fluoride, 1 mM EGTA, 5 mM EDTA, 5 mM DTT, and complete protease inhibitor cocktail (Roche), at 1 mg tissue/20 µl buffer) and centrifuged at 500 x g for 5 min. The supernatants were further centrifuged at 100,000 x g for 1 h, and the resulting supernatants were used. The levels of carbonylated proteins in these supernatants were evaluated by measuring absorbance derived from dinitrohenyl (DNP)hydrazone as previously described (35) with slight modifications. We started with 40 µg of protein and used 6% SOD for a solubilization of the trichloroacetic acid precipitates.
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